|
NICU special delivery: new OxyAlert™ NIRSensors.
Somanetics - the name to trust for evidence-based cerebral and somatic oximetry - welcomes to the world OxyAlert™ NIRSensors for infants and neonates. These patient-friendly sensors feature a gentle, medical-grade hydrocolloid adhesive and a flexible sensor pad that conforms to tight curvatures and small areas. Now, continuous, noninvasive monitoring in up to four site-specific areas is available for your fragile patients.
NIRS FLASH!
-
| PROOF POSITIVE | Hani Hennein, MD Chief, Pediatric Cardiothoracic Surgery Director of Surgical Research Rainbow Babies & Children's Hospital University Hospitals Health System Neonatology Today, July 2006
"Cerebral and somatic oximetry incrementally increases the safety and confidence with which we treat our neonatal and pediatric cardiac surgery patients.
" |
Download materials: Infant Neonatal Brochure OxyAlert™ NIRSensor Spec sheet The SCR™ Newsletter - Pediatric/Neonate
Does monitoring really matter?
Yes! The INVOS® System provides numerous benefits to both the care team and patient. This is a major reason why it is used in 1,200 international installs and 700+ U.S. hospitals, including 80% of the hospitals performing pediatric cardiac surgery. Many of these benefits have been reported in published medical papers or at medical conferences. In all, there are more than 600 clinical references citing the value of the INVOS® System. Clinicians are increasing their ability to detect and correct oxygen problems such as those associated with brain damage, seizures, kidney failure and shock. Whether used in the NICU, OR, or the cardiac cath lab, the clinical benefits derived from the INVOS® System are ones you'll want to share with your patients.
Early Detection is the Best Gift of All

OxyAlert™ NIRSensors are engineered with safety in mind to noninvasively detect perfusion problems in NICU patients.
While most traditional vital signs, lab draws and subjective assessments reflect systemic status or may be time-delayed, the 6th-generation, clinically-proven INVOS® System immediately detects site-specific changes in blood oxygenation. In fact, INVOS® System monitoring has been shown to be a better indicator of regional oxygenation issues than systemic vital signs (ie. MAP, SpO2, ABGs and lactates1-3). This real-time data enables you to intervene early and prevent or lessen the severity or injury of ischemic complications.
Get a Grip on Neonatal Challenges
Many diagnoses and procedures carry a risk of hemodynamic instability to NICU patients. The following diseases and afflictions are just a sample of the kinds of neonatal challenges that can be improved upon; in terms of identification and management of regional hypoxia or ischemia by using rSO2 data.
- Congenital heart disease
- Patent ductus arteriosus (PDA)
- Low cardiac output states
- ECMO; initiation, flow rates, weaning
- Sepsis and shock
- Hyperventilation / over expansion of lungs
- Feeding intolerance / necrotizing enterocolitis (NEC)
- Congenital diaphragmatic hernia
- Asphyxia / Hypoxic-ischemic encephalopathy (HIE)
- Nitric oxide usage
The Benefits of Monitoring with the INVOS System:
- Noninvasive to infants and neonates - no pain, no needlestick, and no procedure to undergo.
- Real time, objective data provides a better indicator of site-specific oxygenation issues than time-delayed or intermittent metrics.
- 2- or 4-channel monitoring allows you to investigate specific areas of interest.
- Concrete data lessens the reliance on subjective assessments (such as skin color and capillary refill time).
- Data helps determine whether vascular beds surrounding various organs are adequately oxygenated.
- Immediately shows patient responses to care and interventions.
- Allows you to make associations of changes between cerebral/somatic rSO2 values (for example, one possible early indicator is peripheral circulation shutting down to preserve the brain).
- Provides a 24/7 watch over your most fragile patients giving you a greater level of control and confidence in keeping your patients safe.
Footnotes: 1. Hoffman GM, et al. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005, pp 12-21. 2. Tobias JD. Anesthesiology 2006; 105:A240. 3. Hoffman GM, et al. Anesthesiology. 2005;103:A1327.
|